Clinical Trials Directory

Trials / Completed

CompletedNCT06968416

12-Week Efficacy Clinical Study of Serum

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
73 (actual)
Sponsor
ChinaNorm · Industry
Sex
Female
Age
25 Years – 55 Years
Healthy volunteers
Accepted

Summary

65 female adult subjects will be enrolled in the study, recruited according to inclusion and non-inclusion criteria listed above. At least 40 subjects should complete the clinical evaluation and 60 subjects should complete consumer questionnaire in this 15-week study (wash-out phase for 3 weeks and treatment phase for 12 weeks). Subjects will need to refrain from using any product other than the provided test products on whole face including eye area during the 3-week wash-out phase and 12-week study treatment phase.

Conditions

Interventions

TypeNameDescription
OTHERStandard cleanser,standard moisturizer,standard sunscreen,Investigational serumProducts Application and Usage Instruction 1. Mode of application: T-3W \~ T0 Frequency: AM: Standard cleanser + standard moisturizer + standard sunscreen PM: Standard cleanser + standard moisturizer Caution: No any other skincare or facial make up products are used except provide products 2. Mode of application: T0 \~ T12W Frequency: AM: Standard cleanser + Investigational serum (face and eye) \[FLA #774715 21\] + standard moisturizer + standard sunscreen PM: Standard cleanser + Investigational serum (face and eye) \[FLA #774715 21\] + standard moisturizer Caution: No any other skincare or facial make up products are used except provide products Usage Instruction: Use serum \[FLA #774715 21\] 8-10 drops (0.3ml) on cleansed face and eye skin 2 times a day (AM \& PM).

Timeline

Start date
2023-08-02
Primary completion
2023-11-17
Completion
2023-11-17
First posted
2025-05-13
Last updated
2025-05-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06968416. Inclusion in this directory is not an endorsement.